Compound index

Growth Hormone Secretagogues & GHRH Analogs

CJC-1295

Also known as CJC-1295 with DAC

Early human trialsInvestigational

Last reviewed: 2026-11-19

Evidence status & limitations

Small studies found prolonged hormone changes; this is not proof of improved health or long-term safety.

Regulatory status

No FDA-approved human medicine for this exact identity was established in this review. Investigational research is not approval.

    Status as of 2026-11-19. Regulations change. Check FDA.gov for current information.

    WADA prohibited status: current list and context

    Known risks & open questions

    FDA notes immune and peptide-impurity concerns; hormone changes can have unwanted metabolic effects.

    Key sources

    Identity and editorial screen completed November 19, 2026. Previously checked primary references retained; this is not an exhaustive clinical review.

    Related compounds

    • Examorelin

      Same scientific class · A 6-amino-acid chain. · Early human trials

    • Ipamorelin

      Same scientific class · A 5-amino-acid chain. · Early human trials

    • Modified GRF (1–29)

      Same target family · A 29-amino-acid chain. · Cell/lab studies only

    • Pralmorelin

      Same scientific class · A 6-amino-acid chain. · Early human trials

    • Sermorelin

      Same target family · A 29-amino-acid chain. · Late-stage human trials

    Related glossary terms